Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02462148 · ClinicalTrials.gov registry record · Phase 4
Perineural Steroids for Peripheral Nerve Blocks
A Phase 4 study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- Phase 4
- Development phase
- 85
- Enrollment target
NCT02462148: Completed Phase 4 study, sponsored by Wake Forest University Health Sciences.
NCT02462148 is a Phase 4 study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 85 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02462148, a Phase 4 study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 85 participants
- Enrollment target
Study Summary
This study will look at the efficacy of dexamethasone for prolongation of peripheral nerve blocks.
Primary Outcome
The primary outcome will be time to resolution of the nerve block as assessed by pinprick over the saphenous nerve distribution. Testing will occur every two hours.
Interventions
- DRUG Bupivacaine
- DRUG Dexamethasone
- DRUG Epinephrine
- PROCEDURE Saphenous Peripheral Nerve Block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2015-07 |
| Est. Completion | 2017-08-31 |
| Phase | Phase 4 |
What the finished NCT02462148 record still lists
NCT02462148 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 85 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (84% lower).
The record links to 0 conditions, and to 4 interventions - of which Bupivacaine is the first listed.
NCT02462148 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02462148 about?
NCT02462148 is a clinical study titled "Perineural Steroids for Peripheral Nerve Blocks". This study will look at the efficacy of dexamethasone for prolongation of peripheral nerve blocks.
What is the current status of trial NCT02462148?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 85 participants. The study started on 2015-07. Estimated completion is 2017-08-31.
What interventions are being tested in trial NCT02462148?
The interventions under investigation include: Bupivacaine (DRUG), Dexamethasone (DRUG), Epinephrine (DRUG), Saphenous Peripheral Nerve Block (PROCEDURE).
Who is sponsoring clinical trial NCT02462148?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02462148's enrollment target sits among peer trials
85 928th of 2000 higher than 1,072 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00842283 · 85 participants
Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target
- NCT02133196 · 85 participants · Phase 2
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
- NCT03823144 · 85 participants · NA
Intravital Microscopy in Human Solid Tumors
- NCT03875638 · 85 participants · Phase 2
Treating Hyperexcitability in AD With Levetiracetam
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia